Cost-effectiveness analysis of gemcitabine plus cisplatin versus fluorouracil plus cisplatin for first-line treatment of recurrent or metastatic nasopharyngeal carcinoma

Autor: Chen, Xudong, Liang, Weiting, Wan, Ning, Zhang, Li, Yang, Yunpeng, Jiang, Jie, Zhang, Tiantian
Zdroj: In Oral Oncology July 2019 94:80-85
Databáze: ScienceDirect